About
Elisigen is a South Korean biotechnology company developing AAV-based gene therapies that target the root causes of diseases such as vision loss and chronic pain by enabling durable, long-term therapeutic protein expression in vivo.
Explore 엘리시젠 / ELISIGEN's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.